Clinical Trials

210 enrolled

Phase 1 Active not recruiting

Neoplasm Metastasis, Neoplasms

NCT04958239 2026-03-17

A Study to Test BI 765179 Alone and in Combination With Ezabenlimab in Patients With Advanced Cancer (Solid Tumors) and BI 765179 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Cancer

151 enrolled

Neoplasms

NCT04802759 2026-03-16

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

316 enrolled

Neoplasm Metastasis

NCT06150157 2026-03-16

A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms

220 enrolled

Neoplasms

NCT06540066 2026-03-16

A Study of BGB-B3227 Alone and in Combination With Tislelizumab in Participants With Advanced or Metastatic Solid Tumors

Phase 1 Terminated

35 enrolled

Neoplasm Metastasis

NCT06997029 2026-03-16

A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors

234 enrolled

Neoplasms

NCT07030712 2026-03-16

MK-8294-001

67 enrolled

Neoplasm Metastasis, Neoplasms

NCT05862285 2026-03-13

UmbrellaMAX

Phase 3 Recruiting

100 enrolled

Neoplasms

NCT05935098 2026-03-13

BGB-A3055 Alone and in Combination With Tislelizumab in Participants With Solid Tumors

Phase 1 Terminated

99 enrolled

Neoplasm Metastasis

NCT06178614 2026-03-13

A Study of JNJ-87890387 for Advanced Solid Tumors

200 enrolled

Neoplasms

NCT06941272 2026-03-13

MK-9999-01C

50 enrolled

Phase 1/2 Active not recruiting

Neoplasms

NCT02908906 2026-03-12

A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Participants With Advanced Cancers

413 enrolled

Neoplasms

NCT05557045 2026-03-12

A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815

332 enrolled

Neoplasm Metastasis

NCT05968326 2026-03-12

IMCODE003

Phase 2 Recruiting

260 enrolled

Phase 2 Active not recruiting

Adenocarcinoma

NCT05993299 2026-03-11

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Untreated Advanced (Metastatic or Unresectable) Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

7 enrolled 15 charts

Neoplasms

NCT06901531 2026-03-11

LUCERNA

Phase 3 Recruiting

500 enrolled

Adenocarcinoma, Neoplasms

NCT03833167 2026-03-10

KEYNOTE-630

450 enrolled 18 charts

Carcinoma, Squamous Cell

NCT06340815 2026-03-06

Varian ProBeam Proton Therapy System Clinical Trial (Shandong)

Phase NA Completed

47 enrolled

Neoplasms

NCT06555744 2026-03-06

A Study of ZW191 in Participants With Solid Tumors

145 enrolled

Neoplasms

NCT06564233 2026-03-06

Supportive Care Intervention for Outpatient Stem Cell Transplant Patients

Phase NA Recruiting

90 enrolled

Neoplasms

NCT06979596 2026-03-06

OMAHA-015

Phase 2 Recruiting

250 enrolled

Phase 1 Not yet recruiting

Neoplasms

NCT07455617 2026-03-06

Study of ABO2102 in KRAS-Mutated Solid Tumors

101 enrolled

Phase NA Active not recruiting

Neoplasm Metastasis

NCT05611632 2026-03-05

NHS-Galleri

142,318 enrolled

Neoplasms

NCT03435796 2026-03-04

Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells

Phase 2/3 Recruiting

1,541 enrolled

Neoplasms

NCT06713369 2026-03-04

AZD5305

8 enrolled

Neoplasm Metastasis, Neoplasms

NCT06803680 2026-03-04

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

90 enrolled

Neoplasm Metastasis

NCT03391778 2026-03-03

Adoptive Cell Therapy Long-term Follow-up (LTFU) Study

250 enrolled

Neoplasms

NCT07046559 2026-03-03

A Single- and Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY4066708 in Healthy Participants

104 enrolled

Neoplasms

NCT05382559 2026-03-02

A Study of ASP3082 in Adults With Advanced Solid Tumors

681 enrolled

Neoplasm Metastasis, Neoplasms

NCT06014658 2026-03-02

Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

130 enrolled

Neoplasms

NCT06884618 2026-03-02

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)

345 enrolled

Neoplasms

NCT07213817 2026-03-02

A Study to Assess the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic, Immunogenicity and Antitumour Activity of IPN60300 in Adults With Locally Advanced or Metastatic Solid Tumours

114 enrolled

Neoplasm Metastasis

NCT01602380 2026-02-27

FALCON

462 enrolled 20 charts

Neoplasm Metastasis, Neoplasms

NCT05377554 2026-02-27

Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery

154 enrolled

Neoplasms

NCT06056791 2026-02-27

CaRe

Phase 1/2 Completed

12 enrolled

Neoplasms

NCT06759649 2026-02-27

A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies

200 enrolled

Neoplasms

NCT07276373 2026-02-27

Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies

50 enrolled

Phase 1 Not yet recruiting

Neoplasms

NCT07438782 2026-02-27

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

97 enrolled

Neoplasms

NCT03976362 2026-02-25

KEYLYNK-008

851 enrolled 25 charts

Carcinoma

NCT06521554 2026-02-25

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

200 enrolled

Phase 2 Active not recruiting

Neoplasm Metastasis

NCT06703346 2026-02-25

Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma

87 enrolled

Neoplasms

NCT07156136 2026-02-25

Study of IMC-P115C in Advanced PRAME-Positive Cancers

140 enrolled

Phase 1 Active not recruiting

Neoplasms

NCT00750841 2026-02-23

Study of the Effect of Rifampicin on the Pharmacokinetics (PK) of Multiple Doses of Cediranib in Patients With Solid Tumours

64 enrolled

Phase 3 Enrolling by invitation

Neoplasm Metastasis

NCT05303532 2026-02-23

ROSY-D

214 enrolled

Neoplasms

NCT06005974 2026-02-23

A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation

Phase 2 Terminated

18 enrolled

Neoplasm Metastasis

NCT06959706 2026-02-20

Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors

50 enrolled

Carcinoma, Neoplasms

NCT07193511 2026-02-20

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

355 enrolled

Phase 1 Active not recruiting

Neoplasm Metastasis

NCT05396833 2026-02-19

Study of Tuvusertib (M1774) in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)

120 enrolled

Neoplasm Metastasis

NCT06818643 2026-02-19

A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)

270 enrolled